Diagnosis and treatment of Cushing's disease in children

Endocrine Development
|December 4, 2009
PubMed

Insights

Cushing's disease (CD) in children is rare and challenging to diagnose and treat. Management requires specialized protocols and long-term follow-up for growth, bone health, and other health aspects into adulthood.

Area of Science:

  • Pediatric Endocrinology
  • Endocrinology
  • Rare Diseases

Background:

  • Cushing's disease (CD) is uncommon in pediatric patients, posing significant diagnostic and therapeutic challenges.
  • Paediatric endocrinologists often lack extensive experience with pediatric CD, necessitating collaboration with adult specialists.
  • Existing diagnostic and management protocols for adult CD require adaptation for the pediatric population.

Purpose of the Study:

  • To outline a diagnostic protocol for pediatric Cushing's disease.
  • To critically appraise current treatment strategies for pediatric CD.
  • To address the long-term management challenges following cure in pediatric CD patients.

Main Methods:

  • Review and adaptation of adult diagnostic protocols for pediatric use.
  • Critical appraisal of established and emerging treatment modalities for CD.
  • Analysis of long-term outcomes including growth, bone health, reproduction, and body composition.

Main Results:

  • A diagnostic protocol, adapted from adult models, is essential for pediatric CD investigation.
  • Treatment strategies require careful consideration of the pediatric context and long-term implications.
  • Post-cure management is crucial for optimizing growth, bone health, reproductive potential, and body composition into adulthood.

Conclusions:

  • Pediatric Cushing's disease necessitates specialized diagnostic and therapeutic approaches.
  • Collaboration between pediatric and adult endocrinology is beneficial for managing this rare condition.
  • Long-term multidisciplinary follow-up is critical for ensuring optimal health outcomes for pediatric CD survivors.

Related Concept Videos

Cushing Syndrome I: Introduction01:26

Cushing Syndrome I: Introduction

Cushing syndrome refers to the collection of clinical manifestations that arise when tissues are exposed to excessive amounts of cortisol or cortisol-like medications over an extended period. Cortisol, a glucocorticoid produced by the adrenal cortex, regulates metabolism, immune responses, and the body’s adaptation to stress. When its concentration remains chronically elevated, these physiological pathways become dysregulated, resulting in the characteristic features of the syndrome.Exogenous...
Cushing Syndrome II: Pathophysiology01:19

Cushing Syndrome II: Pathophysiology

Cortisol production is normally governed by the hypothalamic–pituitary–adrenal (HPA) axis, which maintains hormonal balance through tightly regulated feedback mechanisms. Disruption of this regulatory system is central to the development of Cushing syndrome, whether the excess cortisol originates from external medications or internal pathology. Persistent cortisol elevation alters metabolism, immune function, and endocrine signaling, producing the characteristic clinical features of the...
Adrenal Gland Disorders01:27

Adrenal Gland Disorders

Adrenal gland disorders manifest when the production of adrenal hormones deviates from the norm, resulting in either excessive or insufficient concentrations.
Adrenal insufficiency, characterized by insufficient cortisol and aldosterone production, leads to conditions like Addison's disease. This disorder, affecting the adrenal cortex, exhibits symptoms such as skin bronzing, dehydration, low blood pressure, fatigue, and weight loss. Congenital adrenal hyperplasia, a genetic ailment causing...
Cystic Fibrosis: Management01:24

Cystic Fibrosis: Management

Cystic fibrosis (CF) is an autosomal recessive disorder that predominantly affects individuals of Northern European descent, occurring at a rate of 1 in 3500. It is caused by a genetic mutation in a gene on chromosome 7, most commonly the ΔF508 mutation, that codes for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. This results in thicker mucus secretions and obstruction pathologies in multiple organs, including the lungs and sinuses.
Sinus disease and chronic sinusitis...
Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids01:21

Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids

Glucocorticoids, a class of anti-inflammatory drugs, are pivotal in treating moderate to severe Crohn's disease by inducing remission. They exhibit their anti-inflammatory action by inhibiting the production of inflammatory cytokines such as tumor necrosis factor (TNF)-α, interleukin (IL)-1, and chemokines like IL-8. In addition, they reduce the expression of inflammatory cell adhesion molecules and inhibit gene transcription of nitric oxide synthase, phospholipase A2, cyclooxygenase-2 (COX-2),...
Chronic Pancreatitis II: Collaborative Care01:29

Chronic Pancreatitis II: Collaborative Care

The management of chronic pancreatitis is multifaceted, involving a comprehensive approach that includes thorough assessment, diagnostic testing, and a variety of management strategies.
Assessment: